ÇÁ·Îºê Àçó¸® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÇÁ·Îºê ºÐ·ùº°, ÇÁ·Îºê À¯Çüº°, Á¦Ç°º°, ¹æ¹ýº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Probe Reprocessing Market Size, Share & Trends Analysis Report By Probe Classification (Critical, Semi-Critical), By Probe Type (Convex Probes, Linear Probes), By Product, By Method, By End Use, By Region, And Segment Forecast, 2025 - 2030
»óǰÄÚµå
:
1611059
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2024³â 11¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 120 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÇÁ·Îºê Àçó¸® ½ÃÀå ±Ô¸ð¿Í µ¿Çâ :
¼¼°èÀÇ ÇÁ·Îºê Àçó¸® ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 8¾ï 4,487¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2030³â¿¡ CAGR 10.55%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â º´¿ø³» °¨¿°(HAI) Áõ°¡, °¨¿° °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, º¸°Ç ´ç±¹ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ Áöħ µîÀÌ ÀÖ½À´Ï´Ù. ¿µ»ó Áø´Ü, ³»½Ã°æ °Ë»ç ¹× ±âŸ ½Ã¼ú¿¡¼ ÀÇ·á¿ë ÇÁ·ÎºêÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±³Â÷ ¿À¿°À» ¹æÁöÇϱâ À§ÇØ ÀÌ·¯ÇÑ ÀåºñÀÇ ÀûÀýÇÑ ¼¼Ã´, ¼Òµ¶ ¹× ¸ê±Õ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
ÃÊÀ½ÆÄ ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¼ö³â°£ ÇÁ·Îºê Àçó¸® »ê¾÷ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÊÀ½ÆÄ ±â¼ú Ȱ¿ë¿¡ ´ëÇÑ ¿¬±¸ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ±¹¸³ ÀÇÇÐ µµ¼°üÀÌ 2022³â 8¿ù¿¡ ¹ßÇ¥ÇÑ ¿¬±¸´Â ŸÀ̰Źö±× º´¿ø(TBH)ÀÇ ¹æ»ç¼±°ú¿¡¼ ÃÊÀ½ÆÄÀÇ »ç¿ë ÇöȲÀ» ºÐ¼®Çß½À´Ï´Ù. ÀÌ ¿¬±¸¿¡¼´Â 2013-2019³â±îÁö ÃÊÀ½ÆÄ °Ë»ç·®À» ºñ±³ÇÑ °á°ú, ÀÌ¿ë·üÀÌ 12% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç´Â ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ¿¡ ÀÌ¾î µÎ ¹øÂ°·Î ¸¹ÀÌ ½ÃÇàµÇ´Â Àü¹® ¿µ»ó Áø´Ü ¹æ¹ýÀÓÀº º¯ÇÔÀÌ ¾ø½À´Ï´Ù.
¶ÇÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¸¦ ¹è°æÀ¸·Î ½ÉÀå Áø´ÜÀ» À§ÇÑ ½ÉÃÊÀ½ÆÄ °Ë»ç(ÃÊÀ½ÆÄ¸¦ ÀÌ¿ëÇÑ ½ÉÀå °Ë»ç)ÀÇ ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÃÊÀ½ÆÄ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.2024³â 1¿ù MedStar Health°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹¿¡¼´Â ¿¬°£ 700¸¸ °ÇÀÇ ½ÉÃÊÀ½ÆÄ °Ë»ç°¡ ½Ç½ÃµË´Ï´Ù. ½ÉÃÊÀ½ÆÄ °Ë»ç°¡ ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ½ÉÀå ÃÊÀ½ÆÄ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó À§»ó¹è¿ ÇÁ·Îºê ¹× ½ÉÀå ÇÁ·Îºê¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí, ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇÑ ÇÁ·Îºê Àçó¸® ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ´õ¿í ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ ³ôÀº ¼öÁØÀÇ ¼Òµ¶Á¦ ¹× ÀÚµ¿ ÇÁ·Îºê Àçó¸® ½Ã½ºÅÛ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CS Medical LLC ¹× Nanosonics¿Í °°Àº ÁÖ¿ä ¾÷°è ±â¾÷Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Nanosonics´Â 2022³â 11¿ù ¿µ±¹°ú ¾ÆÀÏ·£µå ½ÃÀåÀ» °Ü³ÉÇØ ¹«¼± ÇÁ·Îºê Ȧ´õ, AuditPro, Soluscope Serie-TEE, UPS ºê·¡Å¶ µî 4Á¾ÀÇ ½ÅÁ¦Ç°À» Ãâ½ÃÇß½À´Ï´Ù. AuditPro´Â ÃßÀû¼º°ú ÄÄÇöóÀ̾𽺸¦ °ÈÇϱâ À§ÇØ ¼³°èµÈ µðÁöÅÐ °¨¿° °ü¸® ¼Ö·ç¼ÇÀ¸·Î AuditPro Digital Logbook, AuditPro Infection Control Management Solution µî ´Ù¾çÇÑ ¸ÂÃãÇü ¹öÀüÀÌ ÀÖ½À´Ï´Ù.
¶ÇÇÑ ÇÁ·Îºê Àç󸮿¡ ´ëÇÑ ÀÚµ¿ÈÀÇ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾÷°è Âü¿©Àڵ鿡°Ô Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÚµ¿È ½Ã½ºÅÛÀº ÀÎÀû ¿À·ùÀÇ À§Çè°ú ¼Òµ¶ Áֱ⠰£ ºÒÀÏÄ¡ ÃÖ¼ÒÈ, ¼öÀÛ¾÷À¸·Î ÀÎÇÑ Á÷¿ø °³ÀÔ Çʿ伺 °¨¼Ò, °³Àκ¸È£Àåºñ(PPE) ¿ä±¸ »çÇ× °¨¼Ò, Ç¥ÁØ ÀÛ¾÷ ÀýÂ÷(SOP) Áؼö °³¼±, ÀÇ·á ºÎ¹® Àü¹ÝÀ¸·Î È®ÀåÇϱ⠽¬¿î ¿öÅ©ÇÃ·Î¿ì °£¼ÒÈ µî ¿©·¯ °¡Áö ÀÌÁ¡ÀÌ ÀÖÀ¸¹Ç·Î ÁöÁö¹Þ°í ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå °³¿ä
Á¦3Àå ÇÁ·Îºê Àçó¸® º¯¼ö, µ¿Çâ, ¹üÀ§
½ÃÀå °èÅë Àü¸Á
¸ð½ÃÀå Àü¸Á
°ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
ÇÁ·Îºê Àçó¸® ºÐ¼® Åø
¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
PESTEL ºÐ¼®
Á¦4Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : ºÎ¹® ºÐ¼®, ÇÁ·Îºê ºÐ·ùº°, 2018-2030³â(¹é¸¸ ´Þ·¯)
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÇÁ·Îºê ºÐ·ù Àü¸Á°ú ÁÖ¿ä Æ÷ÀÎÆ®
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÇÁ·Îºê ºÐ·ù º¯µ¿ ºÐ¼®
ÇÁ·Îºê ºÐ·ùº°
Å©¸®Æ¼ÄÃ
Å©¸®Æ¼Äà ½ÃÀå, 2018-2030³â
¼¼¹Ì Å©¸®Æ¼ÄÃ
¼¼¹Ì Å©¸®Æ¼Äà ½ÃÀå, 2018-2030³â
ºñÅ©¸®Æ¼ÄÃ
ºñÅ©¸®Æ¼Äà ½ÃÀå, 2018-2030³â
Á¦5Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : ºÎ¹® ºÐ¼®, ÇÁ·Îºê À¯Çüº°, 2018-2030³â(¹é¸¸ ´Þ·¯)
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÇÁ·Îºê À¯Çü Àü¸Á°ú ÁÖ¿ä Æ÷ÀÎÆ®
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÇÁ·Îºê À¯Çü º¯µ¿ ºÐ¼®
ÇÁ·Îºê À¯Çüº°
ÄÁº¤½º ÇÁ·Îºê
ÄÁº¤½º ÇÁ·Îºê ½ÃÀå, 2018-2030³â
¼±Çü ÇÁ·Îºê(ºñÅ©¸®Æ¼ÄÃ)
¼±Çü ÇÁ·Îºê ½ÃÀå, 2018-2030³â
°æ½Äµµ(TEE) ÇÁ·Îºê
´Ü°è ¾î·¹ÀÌ/½ÉÀå ÇÁ·Îºê
´Ü°è ¾î·¹ÀÌ/½ÉÀå ÇÁ·Îºê ½ÃÀå, 2018-2030³â
°³» ÇÁ·Îºê
°³» ÇÁ·Îºê ½ÃÀå, 2018-2030³â
±âŸ
Á¦6Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : ºÎ¹® ºÐ¼®, Á¦Ç° À¯Çüº°, 2018-2030³â(¹é¸¸ ´Þ·¯)
ÇÁ·Îºê Àçó¸® ½ÃÀå : Á¦Ç° À¯Çü Àü¸Á°ú ÁÖ¿ä Æ÷ÀÎÆ®
ÇÁ·Îºê Àçó¸® ½ÃÀå : Á¦Ç° À¯Çü º¯µ¿ ºÐ¼®
Á¦Ç° À¯Çüº°
±â±â
±â±â ½ÃÀå, 2018-2030³â
ÀÚµ¿ Àç󸮱â
UV-C ¼Òµ¶±â
¼öµ¿ Àç󸮱â/ħÁö ½ºÅ×À̼Ç
ÃÊÀ½ÆÄ ÇÁ·Îºê º¸°ü ijºñ´Ö
¼Ò¸ðǰ
¼ºñ½º
Á¦7Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : ºÎ¹® ºÐ¼®, ¹æ¹ýº°, 2018-2030³â(¹é¸¸ ´Þ·¯)
ÇÁ·Îºê Àçó¸® ½ÃÀå : ¹æ¹ý Àü¸Á°ú ÁÖ¿ä Æ÷ÀÎÆ®
ÇÁ·Îºê Àçó¸® ½ÃÀå : ¹æ¹ý º¯µ¿ ºÐ¼®
¹æ¹ýº°
¸ê±Õ
°í·¹º§ ¼Òµ¶
°í·¹º§ ¼Òµ¶ ½ÃÀå, 2018-2030³â
Áß·¹º§ ¼Òµ¶
Áß·¹º§ ¼Òµ¶ ½ÃÀå, 2018-2030³â
Àú·¹º§ ¼Òµ¶
Àú·¹º§ ¼Òµ¶ ½ÃÀå, 2018-2030³â
Á¦8Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â(¹é¸¸ ´Þ·¯)
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ Àü¸Á°ú ÁÖ¿ä Æ÷ÀÎÆ®
ÇÁ·Îºê Àçó¸® ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
ÃÖÁ¾ ¿ëµµº°
º´¿ø¡¤Áø·á¼Ò
º´¿ø¡¤Áø·á¼Ò ½ÃÀå, 2018-2030³â
Áø´Ü ¿µ»ó ¼¾ÅÍ
Áø´Ü ¿µ»ó ¼¾ÅÍ ½ÃÀå, 2018-2030³â
±âŸ
±âŸ ½ÃÀå, 2018-2030³â(¹é¸¸ ´Þ·¯)
Á¦9Àå ÇÁ·Îºê Àçó¸® ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
Áö¿ª ´ë½Ãº¸µå
½ÃÀå ±Ô¸ð¿Í ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â :
ºÏ¹Ì
À¯·´
¿µ±¹
µ¶ÀÏ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
³ë¸£¿þÀÌ
½º¿þµ§
µ§¸¶Å©
¾Æ½Ã¾ÆÅÂÆò¾ç
ÀϺ»
Áß±¹
Àεµ
È£ÁÖ
Çѱ¹
ű¹
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«°øÈ±¹
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
Äí¿þÀÌÆ®
Á¦10Àå °æÀï ±¸µµ
½ÃÀå Âü¿© ±â¾÷ÀÇ ºÐ·ù
ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®, ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷º°
±â¾÷ ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
ÁÖ¿ä ±â¾÷ °³¿ä
Nanosonics
CIVCO Medical Solutions
Tristel Plc
Ecolab
Germitec
CS Medical LLC
ASP(Fortive Corporation)
Steelco S.p.A.
Metrex Research, LLC
STERIS
KSA
¿µ¹® ¸ñÂ÷
Probe Reprocessing Market Size & Trends:
The global probe reprocessing market size was valued at USD 844.87 million in 2024 and is anticipated to grow at a CAGR of 10.55% from 2025 to 2030. The growth can be attributed to the increasing prevalence of Hospital-acquired Infections (HAIs), growing awareness about the importance of infection control, and stringent regulatory guidelines set by health authorities. With the rise in the use of medical probes in diagnostic imaging, endoscopy, and other procedures, the demand for proper cleaning, disinfection, and sterilization of these devices has significantly increased to prevent cross-contamination.
The rising demand for ultrasound procedures is projected to drive the growth of the probe reprocessing industry in the coming years. There is also an increasing need for research on the utilization of ultrasound technologies. For example, a study published by the National Library of Medicine in August 2022 analyzed ultrasound usage within the radiology department at Tygerberg Hospital (TBH). This study compared ultrasound volumes from 2013 to 2019, revealing a 12% increase in utilization. Ultrasound remained the second-most frequently performed specialized imaging procedure after computed tomography.
Moreover, the growing use of echocardiograms-ultrasound-based examinations of the heart-for cardiac diagnostics, driven by the rising prevalence of cardiovascular diseases, is expected to fuel the demand for ultrasound procedures. According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S. As a result, the rising need for cardiac ultrasound is anticipated to increase the demand for phased array or cardiac probes, further driving the need for probe reprocessing solutions to meet this growing demand.
In addition, technological advancements, including the development of high-level disinfectants and automated probe reprocessing systems, are expected to further propel market expansion. Key industry players, such as CS Medical LLC and Nanosonics, are introducing innovative solutions. For instance, in November 2022, Nanosonics launched four new products targeting the UK and Ireland markets: the Wireless Probe Holder, AuditPro, Soluscope Serie-TEE, and the UPS Bracket. AuditPro is a digital infection control management solution designed to enhance traceability and compliance. It is available in tailored versions such as the AuditPro Digital Logbook and AuditPro Infection Control Management Solution.
Moreover, the increasing emphasis on automation in probe reprocessing is expected to create significant opportunities for industry participants. Automated systems are gaining traction due to several advantages, including minimizing the risk of human error and inconsistencies across disinfection cycles, reducing the need for manual staff involvement, lowering personal protective equipment (PPE) requirements, improving compliance with standard operating procedures (SOPs), and streamlining workflows for easier scalability across healthcare departments.
Global Probe Reprocessing Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global probe reprocessing market report on the basis of probe classification, probe type, product type, method, and end use and region:
Probe Classification Outlook (Revenue, USD Million, 2018 - 2030)
Semi-Critical
Non-Critical
Critical
Probe Type Outlook (Revenue, USD Million, 2018 - 2030)
Convex Probes
Linear Probes
Transesophageal (TEE) Probes
Phased Array/Cardiac Probes
Endocavitary Probes
Others
Product Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Automated Reprocessors
UV-C Disinfectors
Manual Reprocessors/Soaking Stations
Ultrasound Probe Storage Cabinets
Consumables
Formulations
Disinfectant Liquids
Disinfectant Wipes
Disinfectant Sprays
Detergent
Enzymatic Detergents
Non-enzymatic Detergents
Service
Method Outlook (Revenue, USD Million, 2018 - 2030)
Sterilization
High-Level Disinfection
Intermediate Level Disinfection
Low-Level Disinfection
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals and Clinics
Diagnostic Imaging Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
Europe
Germany
UK
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Probe classification
1.2.2. Probe Type
1.2.3. Product Type
1.2.4. Method
1.2.5. End Use
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Probe Reprocessing Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Demand For Ultrasound Procedures
3.2.1.2. Rising Incidence of Hospital-Acquired Infections
3.2.1.3. Development Of Advanced Products
3.2.2. Market Restraint Analysis
3.2.2.1. Recalls Of Probe Reprocessing Products
3.3. Probe Reprocessing Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Probe Reprocessing Market - Segment Analysis, by Probe Classification, 2018 - 2030 (USD Million)
4.1. Probe Reprocessing Market: Probe Classification Outlook and Key Takeaways
4.2. Probe Reprocessing Market: Probe Classification Movement Analysis
4.3. Probe Reprocessing Market Estimates & Forecast, by Probe Classification (USD Million)
4.4. Critical
4.4.1. Critical Market, 2018 - 2030 (USD Million)
4.5. Semi-Critical
4.5.1. Semi Critical Market, 2018 - 2030 (USD Million)
4.6. Non-Critical
4.6.1. Non-critical Market, 2018 - 2030 (USD Million)
Chapter 5. Probe Reprocessing Market - Segment Analysis, by Probe Type, 2018 - 2030 (USD Million)
5.1. Probe Reprocessing Market: Probe Type Outlook and Key Takeaways
5.2. Probe Reprocessing Market: Probe Type Movement Analysis
5.3. Probe Reprocessing Market Estimates & Forecast, by Probe Type (USD Million)
5.4. Convex Probes
5.4.1. Convex Probes Market, 2018 - 2030 (USD Million)
5.5. Linear Probe (Non-critical)
5.5.1. Linear Probe Market, 2018 - 2030 (USD Million)
5.6. Transesophageal (TEE) Probe
5.6.1. Transesophageal Market, 2018 - 2030 (USD Million)
5.7. Phased Array/Cardiac Probe
5.7.1. Phased Array/Cardiac Probe Market, 2018 - 2030 (USD Million)
5.8. Endocavitary Probe
5.8.1. Endocavitary Probe Market, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Probe Reprocessing Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Million)
6.1. Probe Reprocessing Market: Product Type Outlook and Key Takeaways
6.2. Probe Reprocessing Market: Product Type Movement Analysis
6.3. Probe Reprocessing Market Estimates & Forecast, by Product Type (USD Million)
6.4. Instruments
6.4.1. Instruments Market, 2018 - 2030 (USD Million)
6.4.2. Automated Reprocessors
6.4.2.1. Automated Reprocessor Market, 2018 - 2030 (USD Million)
6.4.3. UV-C Disinfectors
6.4.3.1. UV-C disinfectors Market, 2018 - 2030 (USD Million)
6.4.4. Manual Reprocessors/Soaking Stations
6.4.4.1. Manual Reprocessors/Soaking Stations Market, 2018 - 2030 (USD Million)
6.4.5. Ultrasound Probe Storage Cabinets
6.4.5.1. Ultrasound Probe Storage Cabinets Market, 2018 - 2030 (USD Million)
6.5. Consumables
6.5.1. Consumables Market, 2018 - 2030 (USD Million)
6.5.1.1. Formulations
6.5.1.1.1. Formulations Market, 2018 - 2030 (USD Million)
6.5.1.1.2. Disinfectant Wipes
6.5.1.1.2.1. Disinfectant Wipes Market, 2018 - 2030 (USD Million)
6.5.1.1.3. Disinfectant Liquids
6.5.1.1.3.1. Disinfectant Liquids Market, 2018 - 2030 (USD Million)
6.5.1.1.4. Disinfectant Sprays
6.5.1.1.4.1. Disinfectant Sprays Market, 2018 - 2030 (USD Million)
6.5.1.2. Detergent
6.5.1.2.1. Detergent Market, 2018 - 2030 (USD Million)
6.5.1.2.2. Enzymatic Detergents
6.5.1.2.2.1. Enzymatic Detergents Market, 2018 - 2030 (USD Million)
6.5.1.2.3. Non-Enzymatic Detergents
6.5.1.2.3.1. Non-Enzymatic Detergents Market, 2018 - 2030 (USD Million)
6.6. Service
6.6.1. Service Market, 2018 - 2030 (USD Million)
Chapter 7. Probe Reprocessing Market - Segment Analysis, by Method, 2018 - 2030 (USD Million)
7.1. Probe Reprocessing Market: Method Outlook and Key Takeaways
7.2. Probe Reprocessing Market: Method Movement Analysis
7.3. Probe Reprocessing Market Estimates & Forecast, by Method (USD Million)
7.4. Sterilization
7.4.1. Sterilization Market, 2018 - 2030 (USD Million)
7.5. High-Level Disinfection
7.5.1. High-Level Disinfection Market, 2018 - 2030 (USD Million)
7.6. Intermediate Level Disinfection
7.6.1. Intermediate Level Disinfection Market, 2018 - 2030 (USD Million)
7.7. Low-Level Disinfection
7.7.1. Low-Level Disinfection Market, 2018 - 2030 (USD Million)
Chapter 8. Probe Reprocessing Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
8.1. Probe Reprocessing Market: End Use Outlook and Key Takeaways
8.2. Probe Reprocessing Market: End Use Movement Analysis
8.3. Probe Reprocessing Market Estimates & Forecast, by End Use (USD Million)
8.4. Hospitals and Clinics
8.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
8.5. Diagnostics Imaging Centers
8.5.1. Diagnostics Imaging Centers Market, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018 - 2030 (USD Million
Chapter 9. Probe Reprocessing Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Recent Developments & Impact Analysis by Key Market Participants
10.3. Company Market Share Analysis, 2024
10.4. Key Company Profiles
10.4.1. Nanosonics
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. CIVCO Medical Solutions
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Tristel Plc
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Ecolab
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Germitec
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. CS Medical LLC
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. ASP (Fortive Corporation)
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Steelco S.p.A.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Metrex Research, LLC
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. STERIS
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
°ü·ÃÀÚ·á